Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies

International Journal of Cancer

Volumn 137, Issue 8, 2015, Pages 1967-1978

  Gong, Ting Ting ^a   Wu, Qi Jun ^a   Wang, Yong Lai ^a   Ma, Xiao Xin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

adiponectin; endometrial neoplasm; leptin; meta analysis; obesity

Indexed keywords

ADIPONECTIN; LEPTIN; TUMOR MARKER; ADIPOQ PROTEIN, HUMAN;

ADIPOSE TISSUE; ANGIOGENESIS; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL PROLIFERATION; COHORT ANALYSIS; ENDOMETRIUM CANCER; FEMALE; HUMAN; META ANALYSIS; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RISK REDUCTION; BIBLIOGRAPHIC DATABASE; BLOOD; ENDOMETRIAL NEOPLASMS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR;

ADIPONECTIN; DATABASES, BIBLIOGRAPHIC; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LEPTIN; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84938975246     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29561     Document Type: Article

References (46)

1. Ferlay J, Soerjomataram I, Ervik M, et al.,. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed: September 1, 2014.
2. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
3. Key TJ, Pike MC,. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988; 57: 205-12.
4. van Kruijsdijk RC, van der Wall E, Visseren FL,. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009; 18: 2569-78. [PMC][10.1158/1055-9965.EPI-09-0372] [19755644]
5. Mohammadzadeh G, Zarghami N,. Hypoadiponectinemia in obese subjects with type II diabetes: a close association with central obesity indices. J Res Med Sci 2011; 16: 713-23.
6. Arita Y, Kihara S, Ouchi N, et al., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 2012; 425: 560-1999.
7. Lihn AS, Pedersen SB, Richelsen B,. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
8. Roberts DL, Dive C, Renehan AG,. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 2010; 61: 301-16.
9. Somasundar P, Yu AK, Vona-Davis L, et al., Differential effects of leptin on cancer in vitro. J Surg Res 2003; 113: 50-5.
10. Finucane FM, Luan J, Wareham NJ, et al., Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009; 52: 2345-9.
11. Macis D, Guerrieri-Gonzaga A, Gandini S,. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol 2014; 43: 1226-36.
12. Bao Y, Giovannucci EL, Kraft P, et al., A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst 2013; 105: 95-103.
13. An W, Bai Y, Deng SX, et al., Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev 2012; 21: 126-33.
14. Gialamas SP, Sergentanis TN, Antonopoulos CN, et al., Circulating leptin levels and risk of colorectal cancer and adenoma: a case-control study and meta-analysis. Cancer Causes Control 2013; 24: 2129-41.
15. Niu J, Jiang L, Guo W, et al., The association between leptin level and breast cancer: a Meta-analysis. PLoS One 2013; 8: e67349.
16. Luhn P, Dallal CM, Weiss JM, et al., Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2013; 22: 1304-12.
17. Ohbuchi Y, Suzuki Y, Hatakeyama I, et al., A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer. Int J Clin Oncol 2014; 19: 667-73.
18. Wu MM, Chen HC, Chen CL, et al., A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels. PLoS One 2014; 9: e104630.
19. Dallal CM, Brinton LA, Bauer DC, et al., Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the BâFIT cohort. Endocr Relat Cancer 2013; 20: 151-60.
20. Erdogan S, Sezer S, Baser E, et al., Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer. Endocr Relat Cancer 2013; 20: 669-75.
21. Ma Y, Liu Z, Zhang Y, et al., Serum leptin, adiponectin and endometrial cancer risk in Chinese women. J Gynecol Oncol 2013; 24: 336-41.
22. Friedenreich CM, Langley AR, Speidel TP, et al., Case-control study of markers of insulin resistance and endometrial cancer risk. Endocr Relat Cancer 2012; 19: 785-92.
23. Soliman PT, Cui X, Zhang Q, et al., Circulating adiponectin levels and risk of endometrial cancer: the prospective nurses' health study. Am J Obstet Gynecol 2011; 204: 161-7.
24. Ashizawa N, Yahata T, Quan J, et al., Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol 2010; 119: 65-9.
25. Cust AE, Kaaks R, Friedenreich C, et al., Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 2007; 92: 255-63.
26. Soliman PT, Wu D, Tortolero-Luna G, et al., Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 2006; 106: 2376-81.
27. Dal Maso L, Augustin LS, Karalis A, et al., Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004; 89: 1160.
28. Petridou E, Mantzoros C, Dessypris N, et al., Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003; 88: 993-7.
29. Petridou E, Belechri M, Dessypris N, et al., Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002; 46: 147-51.
30. Stroup DF, Berlin JA, Morton SC, et al., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. J Am Med Assoc 2000; 283: 2008-12.
31. Danesh J, Collins R, Appleby P, et al., Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc 1998; 279: 1477-82.
32. Yang Y, Zhao LG, Wu QJ, et al., Association between dietary fiber and lower risk of all-cause mortality: a meta-analysis of cohort studies. Am J Epidemiol 2015; 181: 83-91.
33. Hamling J, Lee P, Weitkunat R,., Ambühl M,. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008; 27: 954-70.
34. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
35. Greenland S, Longnecker MP,. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-9.
36. Orsini N, Li R, Wolk A, et al., Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73.
37. Bagnardi V, Zambon A, Quatto P, et al., Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 2004; 159: 1077-86.
38. Royston P,. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 2000; 19: 1831-47.
39. Wu QJ, Yang Y, Vogtmann E, et al., Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann Oncol 2013; 24: 1079-87.
40. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
41. Egger M, Davey SG, Schneider M, et al., Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
42. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
43. Wu X, Yan Q, Zhang Z, et al., acrp30 Inhibits leptin-induced metastasis by downregulating the JAK/stat3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells. Oncol Rep 2012; 27: 1488-96.
44. Catalano S, Giordano C, Rizza P, et al., S. Evidence that leptin through STAT and CREB signaling enhances cyclin d1 expression and promotes human endometrial cancer proliferation. J Cell Physiol 2009; 218: 490-500.
45. Garaulet M, Perex-Llamas F, Fuente T, et al., Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 2000; 143: 657-66.
46. Kaplan RC, Ho GY, Xue X, et al., Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 2007; 16: 1291-3.